Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Partow Kebriaei

Showing results (101-110 of 346) with videos related to

Pageof 35
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|May 13, 2015
Autologous Hematopoietic Stem Cell Transplantation in Dialysis-Dependent Myeloma PatientsRiad El Fakih, Patricia Fox, Uday Popat, et al.
Plos One|June 7, 2013
Manufacture of clinical-grade CD19-specific T cells stably expressing chimeric antigen receptor using Sleeping Beauty system and artificial antigen presenting cellsHarjeet Singh, Matthew J Figliola, Margaret J Dawson, et al.
Haematologica|July 24, 2025
Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single centerBetül Oran, Peter Thall, Amin Alousi, et al.
Melanoma Research|June 16, 2023
Durable control of metastases in an HLA-A2+ patient with refractory melanoma after low-dose radiotherapy in combination with MAGE-A4 T cell therapy: a case reportKewen He, David S Hong, Danxia Ke, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 20, 2013
High-dose chemotherapy and autologous stem cell transplantation for nodular lymphocyte-predominant Hodgkin lymphomaMeghan Karuturi, Chitra Hosing, Michelle Fanale, et al.
Cytotherapy|March 4, 2014
Low rate of infusional toxicity after expanded cord blood transplantationAdham S Bear, Patrick J Hanley, Doyle M Bosque, et al.
Research Square|February 17, 2023
Characteristics and Outcomes of Children, Adolescents and Young Adults with Relapsed/Refractory Non-Hodgkin Lymphoma Undergoing Autologous Stem Cell TransplantYago Nieto, Oren Pasvolsky, Roland Bassett, et al.
American Journal of Hematology|October 10, 2019
Philadelphia chromosome-positive acute lymphoblastic leukemia at first relapse in the era of tyrosine kinase inhibitorsIman Abou Dalle, Hagop M Kantarjian, Nicholas J Short, et al.
Clinical Lymphoma & Myeloma|September 26, 2009
Nonmyeloablative allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib eraRichard Champlin, Marcos de Lima, Partow Kebriaei, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 29, 2017
Impact of Fluid Overload as New Toxicity Category on Hematopoietic Stem Cell Transplantation OutcomesGabriela Rondón, Rima M Saliba, Julianne Chen, et al.
Pageof 35

Showing results (101-110 of 346) with videos related to

Sort By:
Pageof 35
Clinical Lymphoma, Myeloma & Leukemia|May 13, 2015
Autologous Hematopoietic Stem Cell Transplantation in Dialysis-Dependent Myeloma PatientsRiad El Fakih, Patricia Fox, Uday Popat, et al.
Plos One|June 7, 2013
Manufacture of clinical-grade CD19-specific T cells stably expressing chimeric antigen receptor using Sleeping Beauty system and artificial antigen presenting cellsHarjeet Singh, Matthew J Figliola, Margaret J Dawson, et al.
Haematologica|July 24, 2025
Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single centerBetül Oran, Peter Thall, Amin Alousi, et al.
Melanoma Research|June 16, 2023
Durable control of metastases in an HLA-A2+ patient with refractory melanoma after low-dose radiotherapy in combination with MAGE-A4 T cell therapy: a case reportKewen He, David S Hong, Danxia Ke, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 20, 2013
High-dose chemotherapy and autologous stem cell transplantation for nodular lymphocyte-predominant Hodgkin lymphomaMeghan Karuturi, Chitra Hosing, Michelle Fanale, et al.
Cytotherapy|March 4, 2014
Low rate of infusional toxicity after expanded cord blood transplantationAdham S Bear, Patrick J Hanley, Doyle M Bosque, et al.
Research Square|February 17, 2023
Characteristics and Outcomes of Children, Adolescents and Young Adults with Relapsed/Refractory Non-Hodgkin Lymphoma Undergoing Autologous Stem Cell TransplantYago Nieto, Oren Pasvolsky, Roland Bassett, et al.
American Journal of Hematology|October 10, 2019
Philadelphia chromosome-positive acute lymphoblastic leukemia at first relapse in the era of tyrosine kinase inhibitorsIman Abou Dalle, Hagop M Kantarjian, Nicholas J Short, et al.
Clinical Lymphoma & Myeloma|September 26, 2009
Nonmyeloablative allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib eraRichard Champlin, Marcos de Lima, Partow Kebriaei, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 29, 2017
Impact of Fluid Overload as New Toxicity Category on Hematopoietic Stem Cell Transplantation OutcomesGabriela Rondón, Rima M Saliba, Julianne Chen, et al.
Pageof 35